Quick Answer
Xeris Biopharma Holdings, Inc. reported Shares Outstanding of 166.22 million shares for fiscal year 2025.
Xeris Biopharma Holdings, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 166.22M | +11.2% |
| 2024 | 149.43M | +8.2% |
| 2023 | 138.13M | +1.4% |
| 2022 | 136.27M | +9.1% |
| 2021 | 124.87M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 165.53M | +11.1% | +2.7% |
| June 30, 2025 | 161.22M | +8.3% | +3.3% |
| March 31, 2025 | 156.01M | +5.3% | +4.4% |
| December 31, 2024 | 149.43M | +8.2% | +0.3% |
| September 30, 2024 | 149.00M | +7.9% | +0.0% |
| June 30, 2024 | 148.94M | +7.9% | +0.5% |
| March 31, 2024 | 148.22M | +8.0% | +7.3% |
| December 31, 2023 | 138.13M | +1.4% | +0.0% |
- Xeris Biopharma Holdings, Inc. showed an increase of +11.2% in Shares Outstanding compared to the prior fiscal year.
- Over the 2021–2025 period, Xeris Biopharma Holdings, Inc.’s shares outstanding has grown by 33.1% (from 124.87 million shares to 166.22 million shares).
- The most recent figure is from Xeris Biopharma Holdings, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 2, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: